JOSLIN: Phase 3 Trial Finds Oral Empagliflozin Provided Safe Glycemic Control in Children with Type 2 Diabetes
|
EINSTEIN: Targeting Nerves to the Liver as Potential Diabetes Treatment
|
UCSD-UCLA: Supplementation with amino acid serine eases neuropathy in diabetic mice
|
STANFORD: NIH grant establishes Stanford Medicine as center of national diabetes training program
|
UAB: Type 1 diabetes: Maintaining the enzyme ACE2 in the gut prevents diabetic blindness
|
VANDERBILT: Study may lead to new diabetes, heart disease treatments
|
WUSTL: Study reveals obesity-related trigger that can lead to diabetes
|
YALE: 3 Things To Know About Teplizumab, the New Diabetes Drug
|
COLUMBIA: Positively Charged Nanomaterials Treat Obesity Anywhere You Want
|
INDIANA: IU research contributes to first FDA-approved drug to delay onset of type 1 diabetes
|